The Board congratulated the COO on her new role with VHI and acknowledged her extraordinary contribution to the health services.
The Board reviewed with the CEO and EMT the key aspects from the CEO monthly report and supporting papers which had been circulated prior to the meeting.
The Board discussion focused on the impact of Covid-19 on operations, the COVID-19 Vaccination Programme, the HSE’s response to the Ukraine Crisis, the Theatre Capacity Review, the South Kerry CAMHS Report (Maskey), the RHAs Implementation programme, the Unscheduled Care Report, Assisted Decision Making, the Board Strategic Scorecard, Critical Care Capacity Development Plan, Public Health Reform, the Reconfiguration of Navan Hospital, the Sláintecare Action Plan, the National Maternity Hospital, and an update on the Data Breach Relating to Cyber Attack.
HSE’s response to the Ukraine Crisis
The Board welcomed the work done by the HSE to respond to the Ukraine crisis including the clinical work stream, led by Public Health and the CCO Clinical Advisory Council.
The CEO informed the Board that the EMT had agreed the addition of a Ukraine Crisis response risk to the Corporate Risk Register (CRR) in light of the increased healthcare demands with the large, sudden and unanticipated numbers of people displaced by the invasion of Ukraine and seeking refuge in Ireland, particularly those who are in vulnerable groups. The full risk assessment will be completed as part of the Q2 2022 CRR Review.
COVID-19 Vaccination / Test and Trace Future Operating Model
The Board noted the papers on the Covid-19 Vaccination programme and the update on the 2nd Booster programme circulated in advance of the meeting. In regards to the Test and Trace Programme the Board noted that the future operating model is currently being developed, in consultation with key stakeholders within the HSE, the Irish Medical Organisation and the HPSC. This transition is currently underway with phase one of the transition plan being implemented following the changes to Public Health guidance on February 28, 2022.
The key elements of the HSE’s plan to deliver the second booster were discussed including vaccine administration locations, vaccine type and interval, and the start date of the programme. In response to questions on the impact of changes to the Booster programme the CCO noted that a successful transition to the future GP-led clinical pathway, will be underpinned by enhanced Surveillance systems.
The CEO also updated the Board on the progress to procure Covid-19 Therapies, Sotrovimab and the oral antiviral Paxlovid.
Theatre Capacity Review
The CEO informed he has recently engaged with the EMT to review and assess the next steps needed to increase theatre capacity throughput, to update and extend this improvement initiative to a number of additional sites. The outcome of this will be reported to the Board in the coming months.
Updated on South Kerry CAMHS (“Maskey”) Report Implementation
The CEO advised that the National Oversight Group, which has met 4 times to date, has been tasked with overseeing, monitoring and reporting on the implementation of the Maskey Report. The Group will continue to meet regularly to ensure timely progress is made on both national and local actions, as part of an overall integrated implementation framework. The Board noted that the implementation framework currently contains 63 actions arising from the 35 recommendations in the report and delivery of the majority of these actions has already commenced. The Board noted the progress of the three CAHMS audit strands
Assessment of Needs & Disability services
The Board discussed the actions being taken to address the recent High Court judgement on the Standard Operating Procedure (SOP) for the Assessment of Need (AON) for Children. The Board noted that a communication has been issued to the CHOs clarifying that the Preliminary Team Assessment (PTA) is not to be used as the AON and two strands of work are being progressed to develop a logistical response to managing AONs and a Task Group to issue Clinical Guidance on Disability Assessment and AON.
In response to questions on how improvements can be brought about for AON the COO confirmed that the HSE is progressing an initiative through the Sláintecare Access/Waiting List Initiative to address the waiting list for AON.
Finance Update
The Board noted the Finance update included in the CEO report circulated in advance of the meeting.
The CFO advised that the draft revenue I&E financial position at the end of February 2022 shows a YTD deficit of €102.5m or 3.03%, with a significant element of this being driven by the direct impact of COVID-19. In the context of the outlook for 2022, the ongoing uncertainty arising from the impact of Covid-19 has contributed to a significant level of complexity and challenge in terms of managing financial issues and risks. He confirmed the ongoing mitigation of risks and impact, through significant monitoring and engagement via internal governance structures and with the Department via the HBOG process
Independent Review on Unscheduled Care
The CEO and COO briefed the board on the Independent Review on Unscheduled Care in Emergency departments following the recent engagement with the Minister. The Board welcomed a number of actions which have been agreed and are already underway, including a targeted response plan for over 75s and a 3-year USC Improvement & Change Programme.
The Board noted that the Independent Review of Unscheduled Care Performance was commissioned
by the HSE in 2019 to review performance across the nine hospitals was not completed due to Covid, but work is now underway with the sited to assess current status and this work will be incorporated into the 3-year Change and Improvement Plan.
Assisted Decision Making Legislation
The CEO informed the Board that the Assisted Decision Making (Capacity) Act 2015 is to commence in June 2022 and the HSE has undertaken a significant programme of work to prepare staff for its commencement. The commencement of the Act is a major milestone in advancing the rights of individuals to make decisions related to their own lives. The CEO noted that the HSE has highlighted to the Secretary General concerns relating to the absence of deprivation of liberty safeguards (DOLS) for vulnerable persons lacking capacity or persons with complex needs cared for by the health service, where there is a lack of a clear legislative basis governing restraints on liberty with the abolition of the current ward-ship system [excluding those who fall under the Mental Health Act 2001].
The EMT have agreed that this risk will be added to the CRR.
Board Strategic Scorecard Report
The Board considered the current overall rating and the summary of individual reports in the March 2022 Board Strategic Scorecard Report. In response to questions on the progress with recruitment for the Patient/Service User Partnership Plan at all 20 sites, the COO said that recruitment is ongoing to fill remaining posts by the end of Q2 2022. The CCO was asked to consider if it would be appropriate to have a KPI, for the lead time to patients for New Drugs/New Indications, agreed by EMT, where there is a requirement for a Managed Access Programme.
The CEO noted that the assurance rating recommended in the Board Scorecard on the Disability Scorecard –No 7 Reform of Disability Services, was revised downwards from 4 to 3 at the EMT meeting 26 April. Following the discussion, the Board approved the scorecard for submission to the Minister as part of the formal monthly progress update report.
NMH Relocation Project
The Board discussed the progress on the NMH relocation project following the approval of the Legal Framework documents and Constitution by the Board. It was noted that the final drafts of the Legal framework documents and Constitution for the NMH DAC were considered and approved by the Boards of both Hospitals and that the Business case is currently being considered by the Department. It was noted that the HSE consent to the Transfer of Shares from the Religious Sisters of Charity to St. Vincent’s Holdings CLG has been confirmed and that all related Governance and Legal matters have been resolved to the satisfaction of all parties. It was noted that the final drafts of the Legal Framework documents and Constitution for the NMH DAC are to be considered by Cabinet at an upcoming meeting.
Public Health Reform Programme
The Board noted that HSE Public Health Reform Programme continues to make significant progress with the first 5 Consultants in Public Health Medicine posts having commenced on the 28 March with the appointment of Area Directors of Public Health.
Navan Hospital
The Board considered the update on the planned reconfiguration of Our Lady’s Hospital Navan (OLHN) to a Model 2 hospital, with a Model 2 Regional Orthopaedic unit in the CEO report circulated in advance of the meeting. The current acute model of care at OLHN holds significant risks from a governance and clinical care perspective including for the remaining patient cohort who arrive at the ED with unidentified serious conditions. The Board noted the efforts undertaken to date, including the preparation of a communication and engagement strategy with the local community and attempts to meet with local Oireachtas members to progress the planned reconfiguration. The Board expressed their concerns about the risks and supported the reconfiguration. These concerns have also been expressed by clinicians at the hospital and national level. The reconfiguration is also supported by the Safety and Quality Committee of the Board. Following this discussion, the Board agreed that the Chairperson should write to the Minister advising him that the arrangements for reconfiguration will take place within four weeks, and in preparation for this, the Minister may wish for the engagement with Oireachtas members to take place.
Sláintecare Action Plan 2022
The Board noted the papers on the Sláintecare Action Plan 2022 which were circulated in advance of the meeting. The Board considered the key Sláintecare-related deliverables for both the HSE and the DoH for the remainder of this year and suggested that further engagement with the Department should take place to better align the responsibilities with the roles of the HSE and the Department.
Data Breach Relating to Cyber Attack
The Board noted the papers providing an update on the data breach notification process to data subjects impacted by the cyber-attack, which were circulated in advance of the meeting. The Board were informed of the approach and assessment of the HSE Data impact. The Board discussed the nature of the data involved in the cyber-attack and the process by which records were being identified and processed for the formulation of the data breach notification process. It was noted that this approach has been notified in detail to the Data Protection Commissioner, with whom HSE officials will meet in the coming two weeks.
In response to questions on litigation, the Board were informed that the HSE has been liaising with SCA with a view to considering the merits of establishing a scheme through which claims against the HSE relating to the Cyber-Attack can be managed. The Board also discussed the risk of the data being used in the future, however it was noted that the worldwide injunction was secured and that Gardai advice suggests that as time progresses the risk of the data being used decreases.
National Women’s Health Action Plan
The Board discussed with the CEO the Women’s Health Action Plan published by the DoH specifically for 2022. This Action Plan captures much of the work underway already in the area of Women’s Health or planned for 2022 in the HSE. In response to questions it was confirmed that funding has been provided to support the establishment of a Women’s Health Implementation Team within the NWIHP, which is being targeted at driving, co-ordinating and reporting in in the area of women’s health across the HSE. This Team is currently being developed.